By stimulating melanin synthesis through the MC1 receptor, MT-II can reduce the risk of skin photodamage due to UV exposure [18]
Nausea, headache, and dizziness are reported in smaller subsets
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access 193,42 per year only 3,72 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Journal of Psychiatric Research, 77, 4251
But if a patient taking these drugs experiences vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication